Anuh Pharma logo

Anuh Pharma

ANUHPHR NSE

Key Fundamentals

MicrocapPharmaceuticalsHealthcare
Market Cap
₹923 Cr
Volatility
Moderate
P/E Ratio
21.51
EBITDA
₹66.10 Cr
Return on Equity
11.65%
Debt to Equity
0
Book Value
₹35.14
52W High
₹99.5
52W Low
₹67

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

3
  • Company has reduced debt.
  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 24.4%

Weaknesses

1
  • Company has a low return on equity of 13.8% over last 3 years.

Growth Rate

Revenue Growth
15.65% higher than 3Y
Net Income Growth
-13.5% lower than 3Y
Cash Flow Change
-108% higher than 3Y
ROE
-19.77% lower than 3Y
ROCE
-17.84% higher than 3Y
EBITDA Margin (Avg.)
-18.88% higher than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
161
150
172
164
138
166
160
198
186
186
197
202
194
Expenses
148
132
148
145
127
149
145
179
176
174
178
182
178
Operating Profit
14
18
24
19
11
17
15
19
10
12
19
20
16
OPM %
9%
12%
14%
12%
8%
10%
9%
9%
6%
6%
10%
10%
8%
Other Income
3
2
4
3
4
3
1
1
3
1
2
-1
3
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
2
2
2
2
2
2
2
3
3
3
3
3
2
PBT
15
18
25
20
12
18
13
17
11
10
18
16
17
Tax %
24%
23%
24%
22%
22%
17%
22%
28%
24%
23%
25%
25%
32%
Net Profit
12
14
19
15
10
15
10
12
8
8
13
12
11
EPS in Rs
1.17
1.38
1.91
1.53
0.95
1.5
1.03
1.24
0.83
0.76
1.34
1.17
1.14
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
284
326
206
238
321
307
432
487
527
647
662
772
779
Expenses
253
289
183
220
291
284
387
439
476
571
600
709
712
Operating Profit
31
38
23
18
30
23
45
47
52
76
62
62
67
OPM %
11%
12%
11%
8%
9%
8%
10%
10%
10%
12%
9%
8%
9%
Other Income
5
4
8
7
5
4
11
5
6
12
9
4
5
Interest
1
1
1
0
1
1
2
2
1
1
1
1
0
Depreciation
3
2
2
2
2
7
15
12
10
9
9
11
11
PBT
32
38
28
23
32
19
39
39
47
78
61
54
60
Tax %
31%
32%
27%
29%
28%
25%
26%
22%
24%
23%
22%
24%
—
Net Profit
22
26
20
17
23
14
28
31
36
60
47
41
44
EPS in Rs
2.19
2.57
2
1.65
2.33
1.43
2.84
3.05
3.61
5.99
4.73
4.1
4.41
Div. Payout %
27%
24%
31%
42%
29%
48%
26%
29%
28%
21%
16%
37%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
4
13
13
13
13
13
25
25
25
25
25
50
Reserves
97
107
128
137
152
150
166
189
216
266
301
302
Borrowings
0
2
0
2
4
45
14
4
1
3
11
0
Other Liabilities
67
71
48
57
71
119
128
129
163
152
170
205
Total Liabilities
168
193
189
209
240
326
333
347
405
446
507
557
Fixed Assets
9
18
17
17
21
84
71
61
53
49
58
57
CWIP
0
0
0
6
34
0
0
0
0
0
0
0
Investments
43
43
70
66
39
80
31
43
91
97
106
84
Other Assets
116
131
101
120
147
163
230
243
261
300
342
416
Total Assets
168
193
189
209
240
326
333
347
405
446
507
557
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
19
16
26
2
7
49
-19
29
54
13
37
-3
Investing
-12
-5
-20
2
3
-77
52
-8
-43
1
-20
18
Financing
-8
-9
-4
-5
-7
22
-33
-19
-12
-9
-5
-26
Net Cash Flow
-1
2
2
-1
3
-5
0
2
-2
5
12
-12
Free Cash Flow
18
6
25
-5
-22
13
-25
27
52
8
17
-11
CFO/OP
96
78
149
49
56
232
-20
80
130
42
78
16
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
88
84
100
109
85
96
90
102
118
107
119
113
Inventory Days
27
35
72
64
64
98
90
77
66
57
54
90
Days Payable
79
77
102
105
89
166
133
117
139
105
115
114
Cash Conversion Cycle
36
42
70
68
61
28
48
62
46
58
59
89
Working Capital Days
43
48
79
80
65
-10
57
68
61
69
68
92
ROCE %
33%
35%
19%
14%
19%
10%
16%
18%
19%
26%
17%
15%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Anuh Pharma insights

63 extracted metrics + investor summaries across FY05–FY26.

Log in — free

Shareholding Pattern

FIIs0.01%Promot.71.80%Others4.71%Public23.49%As ofJun 2026

Documents

1
Concall - May 2026 May 2026
2
Concall - May 2026 May 2026
3
Concall - Nov 2025 Nov 2025
4
Concall - Aug 2025 Aug 2025
5
Concall - May 2025 May 2025

Frequently Asked Questions about Anuh Pharma

What does Anuh Pharma Ltd do?
Incorporated in 1960, Anuh Pharma Ltd is in the business of manufacturing and selling of Bulk drugs and chemicals[1]
Where is Anuh Pharma Ltd (ANUHPHR) listed?
Anuh Pharma Ltd trades as ANUHPHR on the NSE and under code 506260 on the BSE.
Which sector does Anuh Pharma Ltd belong to?
Anuh Pharma Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Anuh Pharma Ltd?
Anuh Pharma Ltd has a market capitalisation of ₹922.76 Cr, which places it in the Small Cap band.
What is the PE ratio of Anuh Pharma Ltd?
Anuh Pharma Ltd trades at a PE ratio of 21.51, against a book value of ₹35.14 per share.
What is the 52-week high and low of Anuh Pharma Ltd?
Over the last 52 weeks Anuh Pharma Ltd has traded between ₹67 and ₹99.5.
Does Anuh Pharma Ltd pay dividends?
Anuh Pharma Ltd has a dividend yield of 1.64%.
What is the Return on Equity (ROE) of Anuh Pharma Ltd?
Anuh Pharma Ltd reported a return on equity of 11.65%. Its debt-to-equity ratio is 0.00.

Company Information

Incorporated in 1960, Anuh Pharma Ltd is in the business of manufacturing and selling of Bulk drugs and chemicals[1]

Website anuhpharma.com
CEO Mr. Ritesh Bipin Shah MBA
Employees 295
Listed 2008-01-02
Face Value ₹ 5
Issued Size 10,02,24,000

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/ANUHPHR.md for Anuh Pharma Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List